nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicoumarol—NQO1—hematologic cancer	0.507	1	CbGaD
Dicoumarol—NQO1—Cisplatin—hematologic cancer	0.127	0.325	CbGbCtD
Dicoumarol—NQO1—Doxorubicin—hematologic cancer	0.0848	0.218	CbGbCtD
Dicoumarol—CYP2C9—Bexarotene—hematologic cancer	0.034	0.0873	CbGbCtD
Dicoumarol—CYP2C9—Idarubicin—hematologic cancer	0.0281	0.0724	CbGbCtD
Dicoumarol—CYP2C9—Bortezomib—hematologic cancer	0.0208	0.0535	CbGbCtD
Dicoumarol—CYP2C9—Thalidomide—hematologic cancer	0.0181	0.0466	CbGbCtD
Dicoumarol—CYP2C9—Teniposide—hematologic cancer	0.0173	0.0445	CbGbCtD
Dicoumarol—CYP2C9—Ifosfamide—hematologic cancer	0.016	0.0411	CbGbCtD
Dicoumarol—CYP2C9—Imatinib—hematologic cancer	0.0152	0.0392	CbGbCtD
Dicoumarol—CYP2C9—Nilotinib—hematologic cancer	0.0139	0.0356	CbGbCtD
Dicoumarol—CYP2C9—Cisplatin—hematologic cancer	0.00776	0.02	CbGbCtD
Dicoumarol—CYP2C9—Dexamethasone—hematologic cancer	0.00627	0.0161	CbGbCtD
Dicoumarol—CRYZ—hematopoietic system—hematologic cancer	0.00567	0.132	CbGeAlD
Dicoumarol—CRYZ—gonad—hematologic cancer	0.00431	0.1	CbGeAlD
Dicoumarol—CRYZ—blood—hematologic cancer	0.00376	0.0874	CbGeAlD
Dicoumarol—CRYZ—bone marrow—hematologic cancer	0.00364	0.0846	CbGeAlD
Dicoumarol—CRYZ—lung—hematologic cancer	0.00329	0.0766	CbGeAlD
Dicoumarol—CRYZ—testis—hematologic cancer	0.00311	0.0723	CbGeAlD
Dicoumarol—VKORC1—gonad—hematologic cancer	0.00297	0.0691	CbGeAlD
Dicoumarol—NQO1—hematopoietic system—hematologic cancer	0.00242	0.0563	CbGeAlD
Dicoumarol—VKORC1—lung—hematologic cancer	0.00227	0.0528	CbGeAlD
Dicoumarol—CRYZ—lymph node—hematologic cancer	0.00225	0.0524	CbGeAlD
Dicoumarol—VKORC1—testis—hematologic cancer	0.00214	0.0498	CbGeAlD
Dicoumarol—VKORC1—lymph node—hematologic cancer	0.00155	0.0361	CbGeAlD
Dicoumarol—NQO1—lung—hematologic cancer	0.00141	0.0327	CbGeAlD
Dicoumarol—NQO1—testis—hematologic cancer	0.00133	0.0308	CbGeAlD
Dicoumarol—CYP2C9—hematopoietic system—hematologic cancer	0.00116	0.0269	CbGeAlD
Dicoumarol—NQO1—lymph node—hematologic cancer	0.000962	0.0224	CbGeAlD
Dicoumarol—CRYZ—Tretinoin—Alitretinoin—hematologic cancer	0.000838	0.173	CbGdCrCtD
Dicoumarol—CRYZ—Isotretinoin—Alitretinoin—hematologic cancer	0.000838	0.173	CbGdCrCtD
Dicoumarol—CYP2C9—blood—hematologic cancer	0.000766	0.0178	CbGeAlD
Dicoumarol—NQO1—Vincristine—Vinorelbine—hematologic cancer	0.000646	0.134	CbGdCrCtD
Dicoumarol—NQO1—Vincristine—Vinblastine—hematologic cancer	0.000516	0.107	CbGdCrCtD
Dicoumarol—VKORC1—Post-translational protein modification—GCNT1—hematologic cancer	0.000495	0.00887	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—OGG1—hematologic cancer	0.000492	0.00881	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—PML—hematologic cancer	0.000489	0.00876	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—SOD2—hematologic cancer	0.000489	0.00875	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CTNNA1—hematologic cancer	0.000482	0.00863	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—HSPB1—hematologic cancer	0.000479	0.00858	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CASP7—hematologic cancer	0.000452	0.00809	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—LDHD—hematologic cancer	0.000447	0.00801	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—HSPA5—hematologic cancer	0.000443	0.00794	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—ASNS—hematologic cancer	0.000437	0.00782	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—HSP90AA1—hematologic cancer	0.000424	0.00759	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—hematologic cancer	0.000424	0.00759	CbGpPWpGaD
Dicoumarol—VKORC1—Post-translational protein modification—MUC1—hematologic cancer	0.000421	0.00754	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—HDC—hematologic cancer	0.000414	0.00742	CbGpPWpGaD
Dicoumarol—NQO1—Transcriptional activation by NRF2—MAPK8—hematologic cancer	0.000408	0.0073	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—MAPK14—hematologic cancer	0.00039	0.00698	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—hematologic cancer	0.000375	0.00671	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	0.000348	0.00623	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—FOS—hematologic cancer	0.000345	0.00617	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—GCNT4—hematologic cancer	0.000339	0.00607	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	0.000337	0.00603	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—ABL1—hematologic cancer	0.000328	0.00588	CbGpPWpGaD
Dicoumarol—CRYZ—Azacitidine—Pentostatin—hematologic cancer	0.000324	0.0671	CbGdCrCtD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—ABL1—hematologic cancer	0.000324	0.00579	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—MTAP—hematologic cancer	0.000322	0.00577	CbGpPWpGaD
Dicoumarol—CRYZ—Gemcitabine—Cytarabine—hematologic cancer	0.000304	0.0629	CbGdCrCtD
Dicoumarol—VKORC1—Post-translational protein modification—SUMO1—hematologic cancer	0.000297	0.00531	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—BAX—hematologic cancer	0.000296	0.00531	CbGpPWpGaD
Dicoumarol—NQO1—Transcriptional activation by NRF2—PIK3CA—hematologic cancer	0.000294	0.00526	CbGpPWpGaD
Dicoumarol—CRYZ—Azacitidine—Clofarabine—hematologic cancer	0.000289	0.0598	CbGdCrCtD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—CDK2—hematologic cancer	0.000289	0.00517	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CTSZ—hematologic cancer	0.000288	0.00516	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—ANPEP—hematologic cancer	0.000288	0.00516	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—BIRC5—hematologic cancer	0.000281	0.00503	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—ABCC3—hematologic cancer	0.000278	0.00498	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—TXN—hematologic cancer	0.000278	0.00498	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—FAS—hematologic cancer	0.000273	0.00488	CbGpPWpGaD
Dicoumarol—CRYZ—Azacitidine—Nelarabine—hematologic cancer	0.000272	0.0562	CbGdCrCtD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—ESR1—hematologic cancer	0.000272	0.00486	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—DPM1—hematologic cancer	0.000271	0.00485	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—ASNS—hematologic cancer	0.000271	0.00485	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—UGT1A1—hematologic cancer	0.000261	0.00468	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000249	0.00446	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—PREB—hematologic cancer	0.000245	0.00439	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	0.000237	0.00425	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—GCNT1—hematologic cancer	0.000235	0.00421	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	0.000227	0.00407	CbGpPWpGaD
Dicoumarol—CRYZ—Azacitidine—Fludarabine—hematologic cancer	0.000212	0.0439	CbGdCrCtD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000207	0.0037	CbGpPWpGaD
Dicoumarol—VKORC1—Post-translational protein modification—CALR—hematologic cancer	0.000204	0.00365	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	0.000203	0.00364	CbGpPWpGaD
Dicoumarol—CRYZ—Azacitidine—Cytarabine—hematologic cancer	0.0002	0.0414	CbGdCrCtD
Dicoumarol—CRYZ—Azacitidine—Gemcitabine—hematologic cancer	0.0002	0.0414	CbGdCrCtD
Dicoumarol—VKORC1—Metabolism of proteins—MUC1—hematologic cancer	0.0002	0.00358	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000197	0.00352	CbGpPWpGaD
Dicoumarol—CRYZ—Azacitidine—Cladribine—hematologic cancer	0.000195	0.0404	CbGdCrCtD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000194	0.00348	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—MTR—hematologic cancer	0.000185	0.00331	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	0.000185	0.00331	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	0.000185	0.00331	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—hematologic cancer	0.000183	0.00328	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	0.000181	0.00325	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	0.000181	0.00323	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—MDM2—hematologic cancer	0.000178	0.00318	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	0.000176	0.00315	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—RPLP1—hematologic cancer	0.000175	0.00313	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	0.00017	0.00305	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—HSP90AA1—hematologic cancer	0.000168	0.00301	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1B—hematologic cancer	0.000165	0.00295	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	0.000162	0.0029	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	0.000162	0.0029	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—TUBB2A—hematologic cancer	0.00016	0.00287	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	0.000158	0.00282	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	0.000158	0.00282	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	0.000154	0.00275	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—hematologic cancer	0.000152	0.00272	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	0.000152	0.00272	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000152	0.00272	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN1A—hematologic cancer	0.00015	0.00268	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—GSTP1—hematologic cancer	0.000149	0.00267	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—EP300—hematologic cancer	0.000143	0.00255	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—MME—hematologic cancer	0.000142	0.00255	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	0.000141	0.00253	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	0.000141	0.00252	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—SUMO1—hematologic cancer	0.000141	0.00252	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CMA1—hematologic cancer	0.000141	0.00252	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—SPHK1—hematologic cancer	0.000138	0.00247	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—HGF—hematologic cancer	0.000137	0.00246	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—GSTM1—hematologic cancer	0.000137	0.00246	CbGpPWpGaD
Dicoumarol—Acenocoumarol—ALB—hematologic cancer	0.000132	0.469	CrCbGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	0.000132	0.00236	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	0.000132	0.00236	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	0.000131	0.00234	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—ALOX5—hematologic cancer	0.000129	0.00231	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000125	0.00224	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—RPS14—hematologic cancer	0.000123	0.00221	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—PDGFB—hematologic cancer	0.000118	0.00211	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—hematologic cancer	0.000118	0.0021	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	0.000111	0.00199	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—EIF4EBP1—hematologic cancer	0.000108	0.00193	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000105	0.00188	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—FTCD—hematologic cancer	0.0001	0.0018	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PHYH—hematologic cancer	0.0001	0.0018	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GMPS—hematologic cancer	0.0001	0.0018	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.0001	0.00179	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—HSPA5—hematologic cancer	9.99e-05	0.00179	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	9.95e-05	0.00178	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CALR—hematologic cancer	9.68e-05	0.00173	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—FBXW7—hematologic cancer	9.36e-05	0.00168	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SMPD3—hematologic cancer	9.18e-05	0.00164	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—hematologic cancer	8.75e-05	0.00157	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—SLC35B2—hematologic cancer	8.35e-05	0.0015	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—EPHX1—hematologic cancer	8.24e-05	0.00147	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—B3GAT1—hematologic cancer	8.03e-05	0.00144	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ASNS—hematologic cancer	8.03e-05	0.00144	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—DCK—hematologic cancer	8.03e-05	0.00144	CbGpPWpGaD
Dicoumarol—Phenprocoumon—ALB—hematologic cancer	7.91e-05	0.281	CrCbGaD
Dicoumarol—NQO1—Metabolism—HDC—hematologic cancer	7.61e-05	0.00136	CbGpPWpGaD
Dicoumarol—Warfarin—ALB—hematologic cancer	7.02e-05	0.249	CrCbGaD
Dicoumarol—NQO1—Metabolism—CDA—hematologic cancer	6.96e-05	0.00125	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PC—hematologic cancer	6.7e-05	0.0012	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SLC35B2—hematologic cancer	6.47e-05	0.00116	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GBA—hematologic cancer	6.47e-05	0.00116	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—MTAP—hematologic cancer	5.92e-05	0.00106	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—TGFB1—hematologic cancer	5.59e-05	0.001	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTO1—hematologic cancer	5.38e-05	0.000963	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTO1—hematologic cancer	5.31e-05	0.00095	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—FHL2—hematologic cancer	5.27e-05	0.000944	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—AGRN—hematologic cancer	5.17e-05	0.000926	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—UGT1A1—hematologic cancer	5.06e-05	0.000906	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—UGT1A1—hematologic cancer	4.99e-05	0.000893	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	4.98e-05	0.000891	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—IDH2—hematologic cancer	4.9e-05	0.000878	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—HMMR—hematologic cancer	4.9e-05	0.000878	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CCL2—hematologic cancer	4.81e-05	0.000861	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ARNTL—hematologic cancer	4.61e-05	0.000825	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	4.55e-05	0.000815	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CA9—hematologic cancer	4.48e-05	0.000803	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ACP5—hematologic cancer	4.48e-05	0.000803	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NCOR2—hematologic cancer	4.43e-05	0.000792	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—MTR—hematologic cancer	4.39e-05	0.000785	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—IDH1—hematologic cancer	4.22e-05	0.000755	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTT1—hematologic cancer	4.17e-05	0.000747	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTO1—hematologic cancer	4.17e-05	0.000746	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—TXN—hematologic cancer	4.17e-05	0.000746	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ABCC3—hematologic cancer	4.17e-05	0.000746	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SPHK1—hematologic cancer	4.08e-05	0.00073	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—UGT1A1—hematologic cancer	3.92e-05	0.000702	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CRABP1—hematologic cancer	3.81e-05	0.000683	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SLC22A1—hematologic cancer	3.81e-05	0.000683	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ALOX5—hematologic cancer	3.72e-05	0.000665	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NUP98—hematologic cancer	3.6e-05	0.000644	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ADCY7—hematologic cancer	3.49e-05	0.000625	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NCOA3—hematologic cancer	3.49e-05	0.000625	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NUP214—hematologic cancer	3.47e-05	0.000621	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—MTR—hematologic cancer	3.4e-05	0.000608	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ABCG2—hematologic cancer	3.4e-05	0.000608	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ENO2—hematologic cancer	3.33e-05	0.000597	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTT1—hematologic cancer	3.23e-05	0.000579	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	3.21e-05	0.000574	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SDC1—hematologic cancer	3.16e-05	0.000566	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTP1—hematologic cancer	2.89e-05	0.000518	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTP1—hematologic cancer	2.85e-05	0.000511	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CD44—hematologic cancer	2.69e-05	0.000481	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTM1—hematologic cancer	2.66e-05	0.000476	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTM1—hematologic cancer	2.62e-05	0.000469	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.61e-05	0.000468	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYCS—hematologic cancer	2.54e-05	0.000455	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—HSP90AA1—hematologic cancer	2.53e-05	0.000452	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.29e-05	0.000409	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTP1—hematologic cancer	2.24e-05	0.000401	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—FTCD—hematologic cancer	2.22e-05	0.000397	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PHYH—hematologic cancer	2.22e-05	0.000397	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GMPS—hematologic cancer	2.22e-05	0.000397	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.19e-05	0.000393	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ABCB1—hematologic cancer	2.12e-05	0.00038	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.09e-05	0.000374	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.07e-05	0.00037	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTM1—hematologic cancer	2.06e-05	0.000369	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NCOR1—hematologic cancer	2.06e-05	0.000369	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SMPD3—hematologic cancer	2.03e-05	0.000363	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.02e-05	0.000362	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.89e-05	0.000338	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.84e-05	0.00033	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—MTHFR—hematologic cancer	1.82e-05	0.000326	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—B3GAT1—hematologic cancer	1.77e-05	0.000317	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—DCK—hematologic cancer	1.77e-05	0.000317	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ASNS—hematologic cancer	1.77e-05	0.000317	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.73e-05	0.00031	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—HDC—hematologic cancer	1.68e-05	0.000301	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.57e-05	0.00028	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CDA—hematologic cancer	1.54e-05	0.000275	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CG—hematologic cancer	1.53e-05	0.000274	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PC—hematologic cancer	1.48e-05	0.000265	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GBA—hematologic cancer	1.43e-05	0.000256	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.43e-05	0.000256	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CREBBP—hematologic cancer	1.42e-05	0.000254	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CD—hematologic cancer	1.34e-05	0.000241	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ALB—hematologic cancer	1.33e-05	0.000238	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—MTAP—hematologic cancer	1.31e-05	0.000234	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3R1—hematologic cancer	1.27e-05	0.000227	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CB—hematologic cancer	1.17e-05	0.00021	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—FHL2—hematologic cancer	1.16e-05	0.000208	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—AGRN—hematologic cancer	1.14e-05	0.000204	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—IDH2—hematologic cancer	1.08e-05	0.000194	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—HMMR—hematologic cancer	1.08e-05	0.000194	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.02e-05	0.000183	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.02e-05	0.000182	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PTEN—hematologic cancer	1.01e-05	0.000181	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ACP5—hematologic cancer	9.9e-06	0.000177	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CA9—hematologic cancer	9.9e-06	0.000177	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NCOR2—hematologic cancer	9.77e-06	0.000175	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—EP300—hematologic cancer	9.65e-06	0.000173	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—IDH1—hematologic cancer	9.31e-06	0.000167	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTO1—hematologic cancer	9.2e-06	0.000165	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—TXN—hematologic cancer	9.2e-06	0.000165	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ABCC3—hematologic cancer	9.2e-06	0.000165	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SPHK1—hematologic cancer	9.01e-06	0.000161	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.65e-06	0.000155	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CRABP1—hematologic cancer	8.42e-06	0.000151	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SLC22A1—hematologic cancer	8.42e-06	0.000151	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ALOX5—hematologic cancer	8.2e-06	0.000147	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NUP98—hematologic cancer	7.94e-06	0.000142	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.71e-06	0.000138	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.71e-06	0.000138	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NUP214—hematologic cancer	7.66e-06	0.000137	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.58e-06	0.000136	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—MTR—hematologic cancer	7.5e-06	0.000134	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ABCG2—hematologic cancer	7.5e-06	0.000134	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ENO2—hematologic cancer	7.36e-06	0.000132	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CA—hematologic cancer	7.14e-06	0.000128	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTT1—hematologic cancer	7.14e-06	0.000128	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.03e-06	0.000126	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SDC1—hematologic cancer	6.97e-06	0.000125	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.66e-06	0.000119	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.58e-06	0.000118	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.29e-06	0.000113	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NQO1—hematologic cancer	5.93e-06	0.000106	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CD44—hematologic cancer	5.93e-06	0.000106	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—AKT1—hematologic cancer	5.83e-06	0.000104	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.81e-06	0.000104	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYCS—hematologic cancer	5.61e-06	0.0001	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.58e-06	9.98e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.02e-06	8.98e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.95e-06	8.86e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.79e-06	8.57e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.68e-06	8.38e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.55e-06	8.14e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.55e-06	8.14e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.02e-06	7.19e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.54e-06	6.34e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.38e-06	6.04e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.13e-06	5.6e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.97e-06	5.31e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ALB—hematologic cancer	2.93e-06	5.24e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.8e-06	5.02e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.59e-06	4.63e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PTEN—hematologic cancer	2.23e-06	4e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—EP300—hematologic cancer	2.13e-06	3.82e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.58e-06	2.82e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—AKT1—hematologic cancer	1.29e-06	2.31e-05	CbGpPWpGaD
